The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Valeant Pharmaceuticals International Inc

TSX: VRX
Delayed quote

$44.49

Today's change-0.24 -0.54%
Updated May 5 4:00 PM EDT. Delayed by at least 15 minutes.
 

Valeant Pharmaceuticals International Inc

TSX: VRX
Delayed quote

$44.49

Today's change-0.24 -0.54%
Updated May 5 4:00 PM EDT. Delayed by at least 15 minutes.

Valeant Pharmaceuticals International Inc down $0.24

Valeant Pharmaceuticals International Inc closed lower Thursday, dropping $0.24 or 0.54% to $44.49. Over the last five days, shares have gained 0.57%, but are down 68.35% for the last year to date. Shares have underperformed the S&P TSX by 73.02% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward4.65×
  • Forward PEG0.23×
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$1.08
Updated May 5 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.00%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue2,7892,7872,7322,191
Total other revenue--------
Total revenue2,7892,7872,7322,191
Gross profit2,0522,1392,0471,616
Total cost of revenue737648685575
Total operating expense2,5672,3392,3911,668
Selling / general / administrative726698686574
Research & development961028156
Depreciation / amortization775679585365
Interest expense (income), net operating--------
Unusual expense (income)19118217792
Other operating expenses, total43301776
Operating income222448342523
Interest income (expense), net non-operating-432-420-413-298
Gain (loss) on sale of assets--------
Other--------
Income before tax-213-6-65155
Income after tax-33752-5275
Income tax, total124-57-1381
Net income-33650-5374
Total adjustments to net income--------
Net income before extra. items-33650-5374
Minority interest1-2-1-1
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-33650-5374
Inc. avail. to common incl. extra. items-33650-5374
Diluted net income-33650-5374
Dilution adjustment------0
Diluted weighted average shares345351344343
Diluted EPS excluding extraordinary itemsvalue per share-0.980.14-0.150.21
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share-0.470.570.190.34